EGRP News Flash - November 17, 2009
Proposals Sought for Research and Development on Human Biospecimen Integrity
On behalf of the National Cancer (NCI), the Epidemiology and Genetics Research Program (EGRP) would like to make investigators aware of a new American Recovery and Reinvestment Act (ARRA) funding opportunity, Contract Solicitation Number: ST10-1005, Research and Development (R&D) on Human Biospecimen Integrity. Responses to this Request for Proposals (RFP) are due by 2:00 p.m. Eastern Time on December 14, 2009. Selected offerors will contract directly with SAIC-Frederick, Inc., and be subcontractors to it.
Proposals are invited that will significantly advance the field of biospecimen science. This RFP is designed to solicit a broad and diverse range of projects that can:
- Provide data to support development of reference markers for biospecimen integrity;
- Illustrate quality assessment measures for biospecimens used in cancer research and in the development of cancer diagnostics and therapeutics;
- Establish biospecimen monitoring procedures and/or tools to bolster biospecimen quality assurance for cancer research;
- Demonstrate how specific pre-analytical variables affect biospecimen integrity and/or the ability to yield reproducible, high-quality cancer research data; and
- Address how emerging clinical technologies affect the integrity of biospecimens.
The initiative is part of NCI’s Biospecimen Research Network (BRN), which is a group of intramural and extramural partners that conducts biospecimen acquisition and banking research under the direction of the Office of Biorepositories and Biospecimen Research (OBBR).
The BRN seeks to support one or more subcontracts. Projects awarded ARRA funds must be completed within a 2-year period and are subject to additional reporting requirements.